Oxalic acid - Important uremic toxin;Kyselina oxalová - Významný uremický toxín

Vnitrni Lekarstvi

Volumn 56, Issue 7, 2010, Pages 695-701

  Mydlík, Miroslav ^a,b   Derzsiova K ^a  

^a IV Interna Klinika   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Chronic kidney disease (CKD); Maximal water diuresis; Oxalic acid; Renal replacement therapy; Renal transplantation; Salivary oxalic acid; Sodium diuresis; Uremic toxin; Vitamin C

Indexed keywords

ASCORBIC ACID; FUROSEMIDE; OXALIC ACID; OXIDOREDUCTASE; SODIUM CHLORIDE; UREMIC TOXIN; WATER; CREATININE; SALT INTAKE; TOXIN;

ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROL GROUP; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; DIET; DISEASE SEVERITY; DIURESIS; HEMODIAFILTRATION; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PLASMA; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SALIVA; SALT INTAKE; SODIUM URINE LEVEL; SPECTROPHOTOMETRY; URINALYSIS; URINARY EXCRETION; ADULT; CHRONIC DISEASE; FEMALE; KIDNEY DISEASES; MALE; METABOLISM; MIDDLE AGED; PHARMACOLOGY; UREMIA;

ADULT; ASCORBIC ACID; CHRONIC DISEASE; CREATININE; DIURESIS; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OXALIC ACID; RENAL DIALYSIS; SODIUM CHLORIDE, DIETARY; TOXINS, BIOLOGICAL; UREMIA;

EID: 77956325011     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Vanholder R, Argilés A, Baurmeister U et al. Uremic toxicity: present state of the art. Int J Artif Organs 2001; 24: 695-725.
2. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943.
3. Vanholder R, Glorieux G, De Smet R et al. Low water-soluble uremic toxins. Adv Ren Replace Ther 2003; 10: 257-269.
4. Wills MR. Uremic toxins, and their effect on intermediary metabolism. Clin Chem 1985; 31: 5-13.
5. Levin RI, Kantoff PW, Jaffe EA. Uremic levels of oxalic acid suppress replication and migration of human endothelial cells. Atherosclerosis 1990; 10: 198-207.
6. Recht PA, Tepedino GJ, Siecke NW et al. Oxalic acid alters intracellular calcium in endothelial cells. Atherosclerosis 2004; 173: 321-328.
7. Costello JF, Smith M, Stolarski C et al. Extrarenal clearance of oxalate increases with progression of renal failure in the rat. J Am Soc Nephrol 1992; 3: 1098-1104.
8. France NC, Holland PT, Wallace MR. Contribution of dialysis to endogenous oxalate production in patients with chronic renal failure. Clin Chem 1994; 40: 1544-1548.
9. Massry SG, Glassock RJ. Textbook of Nephrology, 2 volume. 3rd ed. Baltimore: Williams & Wilkins 1995.
10. Worcester EM, Fellner SK, Nakagawa Y et al. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron 1994; 67: 414-418.
11. Hatch M, Freel RW, Vaziri ND. Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol 1994; 5: 1339-1343.
12. Boer P, van Leersum L, Hené RJ et al. Plasma oxalate concentration in chronic renal disease. Am J Kidney Dis 1984; 4: 118-122.
13. Salyer WR, Keren D. Oxalosis as a complication of chronic renal failure. Kidney Int 1973; 4: 61-66.
14. Celasun B, Safali M, Yenicesu M. Secondary oxalosis of bone in a dialysis patient. Scand J Urol Nephrol 1995; 29: 211-214.
15. Nakazawa R, Hamaguchi K, Hosaka E et al. Cutaneous oxalate deposition in a hemodialysis patient. Am J Kidney Dis 1995; 25: 492-497.
16. Costello JF, Sadovnic MC, Smith M et al. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients. J Am Soc Nephrol 1992; 3: 1018-1024.
17. Makoff R. Vitamin replacement therapy in renal failure patients. Miner Electrolyte Metab 1999; 25: 349-351.
18. Rathi S, Kern W, Lau K. Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: a case report. J Med Case Report 2007; 1: 155.
19. Ogawa Y, Machida N, Jahana M et al. Major factors modulating the serum oxalic acid level in hemodialysis patients. Front Biosci 2004; 9: 2901-2908.
20. Schück O. Fractional sodium excretion in patients with chronic renal failure with respect to the therapy. Nephron 1982; 30: 95-96.
21. Schück O. Nefrologia pro praktické lékaře. 1. vyd. Praha: Scientia Medica 1993: 156-158.
22. Krämer BK, Pickert A, Hohmann C et al. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes. Int J Artif Organ 1992; 15: 408-412.
23. Hořejší J, Fassati M, Jícha J et al. Základy chemického vyšetřování v lékařství. 4. vyd. Praha: Státní zdravotnické nakladatelství 1964.
24. Rolton HA, McConnell KN, Modi KS et al. A simple, rapid assay for plasma oxalate in uraemic patients using oxalate oxidase, which is free from vitamin C interference. Clin Chim Acta 1989; 182: 247-254.
25. Mydlík M, Derzsiová K, Pribylincová V et al. Urinary excretion of oxalic acid in chronic renal failure and after kidney transplantation. Przegla̧d Lek 1996; 53 (Suppl 3): 65-69.
26. Mydlík M, Derzsiová K, Jenča A et al. Salivary oxalic acid and ascorbic acid in chronic renal failure. Proc Selected Papers of the XIII International Congress on Nutrition and Metabolism in Renal Disease. Merida (Mexico) February 28-March 4, 2006. In: Trevino-Becera A, Pineda-Sanches E, Trinida-Ramos P (eds). Bologna, Italy, Medimond S. r. I. 2006, 39-44.
27. Mydlík M, Derzsiová K, Žemberová E. Influence of water and sodium diuresis and furosemide on urinary excretion of vitamin B6, oxalic acid and vitamin C in chronic renal failure. Miner Electrolyte Metab 1999; 25: 352-356.
28. Mydlík M, Derzsiová K, Žemberová E et al. Vplyv furosemidu na vylučovanie kyseliny oxalovej, vitamínu C a vitamínu B6 pri chronickom zlyhaní obličiek. Vnitř Lék 1998; 44: 127-131.
29. Derzsiová K, Mydlík M, Boldizsár J et al. Perorálne použitie železa s vitamínom C u hemodialyzovaných chorých. Vnitř Lék 2001; 47: 210-214.
30. Mydlík M, Derzsiová K, Šváč J et al. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C and vitamin B6 during continuous ambulatory peritoneal dialysis. Artif Organs 1998; 22: 784-788.
31. Mydlík M, Derzsiová K, Sulková S et al. Peritoneálny klírens a peritoneálny transfer kyseliny oxalovej a kyseliny askorbovej počas kontinuálnej ambulantnej peritoneálnej dialýzy (CAPD). Akt Nefrol 1995; 1: 25-28.
32. Mydlík M, Derzsiová K. Renal replacement therapy and secondary hyperoxalaemia in chronic renal failure. Kidney Int 2001; 59 (Suppl 78): S304-S307.
33. Costello JF, Sadovnic MJ, Cottington EM. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal. J Am Soc Nephrol 1991; 1: 1289-1298.
34. Marangella M, Vitale C, Petrarulo M et al. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes. Nephrol Dial Transplat 1995; 10 (Suppl 8): 11-13.
35. Wahl R, Kallee E. Oxalic acid in saliva, teeth and tooth tartar. Eur J Clin Chem Clin Biochem 1994; 32: 821-825.
36. Mäkilä E. Salivary Vitamins. Int Z Vitamin Forsch 1968; 38: 260-269.
37. Mäkilä E, Kirveskari P. A study of ascorbic acid in human saliva. Arch Oral Biol 1969; 14: 1285-1292.
38. Bates JF, Hughes RE, Hurley RJ. Ascorbic acid status in man: measurements of salivary, plasma and white blood cell concentration. Arch Oral Biol 1972; 17: 1017-1020.
39. Blacow NW, Wade A (eds). Martindale. The Extra Pharmacopoiea. 26th ed. London: The Pharmaceutical Press 1972.
40. Dzúrik R, Dzúriková V. Diuretická liečba. 2. vyd. Martin: Osveta 1981.
41. Boer P, Beutler JJ, van Rijn HJ et al. Urinary oxalate excretion during intravenous infusion of diuretics in man. Nephron 1990; 54: 187-188.
42. Sahun G, Acikalin MF, Yalcin AU. Erythropoietin resistance as a result of oxalosis in bone marrow. Clin Nephrol 2005; 63: 402-404.
43. Dell'Aquila R, Feriani M, Mascalzoni E et al. Oxalate removal by differing dialysis techniques. ASAIO J 1992; 38: 797-800.
44. Mydlík M, Derzsiová K. Oxalic acid as a uremic toxin. J Ren Nutr 2008; 18: 33-39.